What's the outlook for A2 Milk shares in the second quarter?

Are things improving or souring for A2 Milk's future?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Infant formula sales are expected to rise in FY23
  • A2 Milk’s operating profit (EBITDA) is also expected to go up this financial year
  • There are reports of a new potential competitor listing on the ASX – it beat A2 Milk to a US FDA registration

The A2 Milk Company Ltd (ASX: A2M) share price has made some big movements this year, just like plenty of other ASX shares.

In the middle of the year, it dropped to around $4. It's now back to well above $5.

After a significant decline from its peak – in revenue, profit, and share price terms – the infant formula company is now expecting to generate growth in the current financial year.

Remember, the share market is often forward-looking, so an improvement in the outlook for the company can improve investor sentiment. Let's check how things are looking for the FY23 first half and the overall 2023 financial year.

What are FY23 expectations?

China label infant formula sales are expected to be up in FY23 with "significant growth" in sales in the first half of FY23 compared to the first half of FY22. But, at this stage, FY23 second-half sales growth is expected to be impacted by a transition to the company's pending new infant formula registration.

Meantime, English label infant formula sales are expected to be up in FY23, with FY23 first-half sales expected to be broadly in line with the FY22 second half.

Australian liquid milk sales are also expected to remain "broadly in line" with FY22, with reduced in-home consumption. Conversely, USA liquid milk sales are expected to be up, with a "significant" improvement in earnings before interest, tax, depreciation and amortisation (EBITDA) losses.

A2 Milk is expecting to deliver high-single-digit revenue growth in FY23, with first-half revenue up significantly. It's also expecting overall EBITDA growth in FY23.

The company has also launched an on-market share buyback of up to $150 million to return capital to investors. This could help the A2 Milk share price because the value of the business is being spread across fewer shares.

Trading update

A2 Milk gave a small update on 30 September 2022, saying it has made a positive start to the year. It reported FY23 first-quarter sales are expected to be "marginally ahead" of plan, primarily reflecting the benefit of favourable foreign exchange, driven by the lowering of the New Zealand dollar.

Due to the currency impact on the cost of sales and cost of doing business, not forgetting about the benefit to sales, FY23 first quarter EBITDA is expected to be "in line" with the company's plan.

A new competitor?

According to reporting by Australian Financial Review, there is another infant formula business — Care A2 Plus — that is looking to list on the ASX with an initial public offering (IPO). Could another competitor in the space hurt the A2 Milk share price?

This business reportedly uses single-sourced milk from Australian grass-fed a2 cows in Victoria. It has also received approval from the US to supply a large quantity (up to 4.8 million tins) of infant formula to try to alleviate the shortage there. The company applied within 24 hours of news that US import laws would be changing.

More than 250,000 tins are due to ship to the US this month. Conversely, the ASX-listed A2 Milk didn't manage to get approved.

The AFR sources suggested that "Care A2 Plus could have a valuation of $400 million", but the "US win had forced the company to revisit its numbers and what it might mean for any public float".

However, the newspaper also pointed out that this business made "negligible sales" last year. Care A2 Plus management pointed out that the company's capacity is focused on the US, rather than Asia.

Broker rating on the A2 Milk share price

One of the latest ratings comes from Credit Suisse, which rates it as neutral. The price target is $5.25 – implying no capital growth over the next year.

The broker pointed to an increased marketing presence from A2 Milk and thinks that it can grow its market share during FY23.

Credit Suisse thinks that A2 Milk shares are valued at 30 times FY22's estimated earnings.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

Stock market crash concept of young man screaming at laptop on the sofa.
Share Fallers

Guess which ASX 200 stock just crashed 31% on slumping sales

The $1.3 billion ASX 200 stock is getting hammered today.

Read more »

Photo of a happy couple with their new car and car keys.
Consumer Staples & Discretionary Shares

Up 55% this year, why Macquarie believes Eagers Automotive shares can charge higher

Eagers set to capitalise as BYD’s Australian sales surge.

Read more »

Two race cars on a track at sunset.
Consumer Staples & Discretionary Shares

Down 36% in a year, this ASX 300 stock is one to watch

After a major sell-off, this high-performance cooling specialist might be gearing up for a turnaround.

Read more »

Two laughing young women hold shopping bags and ride an escalator up to another level in a Scentre Group shopping centre.
Broker Notes

3 ASX consumer sector shares to buy in July: expert

A leading expert has named its top 3 picks.

Read more »

person with large headphones looking puzzled holding their hand to their chin.
Broker Notes

Does Macquarie prefer Harvey Norman or JB Hi-Fi shares?

Both companies have market-beating long-term track records.

Read more »

Person taking out a slice of pizza from a pizza box.
Consumer Staples & Discretionary Shares

Why now is the time to buy the big dip on Domino's shares

Down 46% in a year, a leading expert forecasts brighter days ahead for Domino’s shares.

Read more »

Three people sit on safe cheering with pizza on table
Consumer Staples & Discretionary Shares

Food fight! Have Guzman Y Gomez shares outperformed Domino's since ASX debut?

Lets find out who’s topping the menu for investors

Read more »

Woman chooses vegetables for dinner, smiling and looking at camera.
Consumer Staples & Discretionary Shares

Here's the Coles dividend forecast from top analysts through to 2029

Can this defensive business provide pleasing payouts? Let’s take a look…

Read more »